Total Funding
59
12
Total FundingSeries D raised
Growth Score 59 in past quarter
-7 pts
Heat Score 12 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
512245
Neomend is a biomedical device company engaged in the development and commercialization of surgical wound healing products.
About the Company
Neomend is a biomedical device company that engages in the development and commercialization of surgical wound healing products. Its platform technology, Pro/PEG, is a bioadhesive polymer hydrogel. NeoMend engages in the commercialization of the combination wound sealant and adhesion barrier product that can be delivered during minimally
invasive/laparoscopic procedures.



